Evaxion Biotech A/S (EVAX)
NASDAQ: EVAX · Real-Time Price · USD
0.852
-0.022 (-2.54%)
Dec 26, 2024, 2:16 PM EST - Market open
Evaxion Biotech Employees
Evaxion Biotech had 49 employees as of December 31, 2023. The number of employees decreased by 14 or -22.22% compared to the previous year.
Employees
49
Change (1Y)
-14
Growth (1Y)
-22.22%
Revenue / Employee
$67,245
Profits / Employee
-$233,898
Market Cap
4.75M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 49 | -14 | -22.22% |
Dec 31, 2022 | 63 | 2 | 3.28% |
Dec 31, 2021 | 61 | 26 | 74.29% |
Dec 31, 2020 | 35 | -1 | -2.78% |
Dec 31, 2019 | 36 | - | - |
Related Stocks
Company Name | Employees |
---|---|
Syros Pharmaceuticals | 68 |
Sintx Technologies | 43 |
Predictive Oncology | 35 |
Theriva Biologics | 22 |
Organovo Holdings | 20 |
Moleculin Biotech | 18 |
Hoth Therapeutics | 3 |
Aptorum Group | 3 |
EVAX News
- 6 weeks ago - Evaxion announces positive preclinical data for cytomegalovirus (CMV) vaccine program EVX-V1 - GlobeNewsWire
- 2 months ago - Evaxion announces business update and third quarter 2024 financial results - GlobeNewsWire
- 2 months ago - Evaxion to announce business update and third quarter 2024 financial results on October 31 - GlobeNewsWire
- 2 months ago - Strong validation of Evaxion's AI-Immunology™ platform in multiple clinical trials - GlobeNewsWire
- 3 months ago - Recent clinical data confirms significantly improved predictive power of Evaxion's AI-Immunology™ platform - GlobeNewsWire
- 3 months ago - Evaxion Biotech Partners With Merck To Expand Vaccine Development - Benzinga
- 3 months ago - Evaxion significantly expands vaccine development collaboration with MSD - GlobeNewsWire
- 3 months ago - Evaxion launches improved AI-Immunology™ platform for vaccine antigen prediction - GlobeNewsWire